- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Global Imaging Market to Reach $26.6 B
The global diagnostic imaging market is expected to swell to $26.6 billion by 2016, driven by an aging population and advancements in the field.
The global diagnostic imaging market is expected to swell to $26.6 billion by 2016, driven by an aging population and advancements in the field.
The imaging market, which stood at $20.7 billion in 2010, is also expected to be bolstered by an increasing awareness about preventive care and development of products “that result in harmless imaging,” according to research firm MarketsandMarkets, whose report analyzes and studies major market drivers.
The market is expected to grow at a compound annual growth rate of 4.2 percent, according to the report which examined geography, forecasting revenues, and trends in X-ray, CT, MRI, ultrasound and nuclear imaging.
Topping the imaging trends garnering attention is the fusion of nuclear imaging with different modalities, such as PET/CT, SPECT/CT, and MRI/PET, according to the report. Portable diagnostic equipment is also facing demand, according to analysts.
In 2010, X-ray constituted the largest percent of market share with around 34 percent, followed by ultrasound at 21 percent, CT scan with 19.5 percent, MRI with 18.5 percent, and nuclear medicine with 7 percent. America dominates the market with around 36.6 percent market share, followed by Europe with 27.3 percent, and Asia with 27 percent. GE, Philips, and Siemens constituted the majority of the market. Toshiba, Hitachi, and Hologic are gaining presences, according to analysts.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
